Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Introduction to migraine and headache disorders
- Epidemiology of headache disorders
- DALYs
- GBD 2019 results: headache disorders
- GBD 2019 results: migraine and TTHs
- Level 3 causes of global disability (YLDs)
- Level 4 causes of global disability (YLDs)
- Level 4 causes of global lost healthy life
- Region by region epidemiology and burden
- European region: 1-year prevalence
- European region: burden (1)
- Personal impact of headache: EU (1)
- Personal impact of headache: EU (2)
- European region: burden (2)
- Asian region: 1-year prevalence
- Asian region: burden (1)
- Asian region: burden (2)
- African region: 1 year prevalence
- African region: burden
- Burden: per person lost productive time and GDP
- Summary
- References (1)
- References (2)
Topics Covered
- Epidemiology and global burden of headache and migraine
- Tension-type headache (TTH) and Migraines
- Probable medication overuse headache (pMOH)
- Disability-adjusted life years (DALYs)
- Level 3 and 4 causes of global disability
- Lost productive time due to headache disorders
Links
Series:
Categories:
Therapeutic Areas:
External Links
Talk Citation
Ogunlaja, O.I. (2023, August 31). Epidemiology and global burden of headache and migraine [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 14, 2024, from https://doi.org/10.69645/KGJI7001.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Oyindamola I. Ogunlaja has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: Toward a Deeper Understanding of Headache and Migraine
Transcript
Please wait while the transcript is being prepared...
0:00
Good morning.
My name is Dr.
Oyindamola Ogunlaja.
I'm a clinical
assistant professor
in the Department of Neurology
at Stanford University.
The title of this talk is
the Epidemiology and Global
Burden of Headache Disorders,
with a particular
emphasis on migraine.
0:20
Primary headache disorders,
in particular migraine,
are a common cause of
disability worldwide.
They're associated with higher
rates of mental health disorders,
such as anxiety and depression,
and reduced economic
productivity,
which negatively impacts the gross
domestic product on a national scale.
In 2016, almost 3
billion people worldwide
were estimated to have migraine
or tension-type headache,
1.89 billion with
tension-type headache
and 1.04 billion with migraine.
0:53
Through the Global
Burden of Disease study,
we have a better understanding
of the scale and impact
of headache disorders worldwide.
The Global Burden
of Disease study,
which I'll refer to
as GBD from now on,
is a worldwide collaboration
currently led by
the Institute for Health
Metrics and Evaluation,
which is part of the
University of Seattle.
It aims to quantify health loss due
to different diseases and injuries
across places and over time.
It's been performed
periodically since 1990,
with the latest
iteration being in 2019.
In this presentation,
we'll talk about the gross worldwide
statistics of headache disorders
and then break down into
region-by-region analyses
of the prevalence of
headache disorders
and the burden
attributable to them.